Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (16304)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 8, 2016 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kim JU, Shariff MIF, Crossey MME, Gomez-Romero M, Holmes E, Cox IJ, Fye HKS, Njie R, Taylor-Robinson SD. Hepatocellular carcinoma: Review of disease and tumor biomarkers. World J Hepatol 2016; 8(10): 471-484 [PMID: 27057305 DOI: 10.4254/wjh.v8.i10.471] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v8/i10/471.htm |
| Number | Citing Articles |
| 1 |
Maryam Ranjpour, Saima Wajid, Swatantra K. Jain. Elevated Expression of A-Raf and FA2H in Hepatocellular Carcinoma is Associated with Lipid Metabolism Dysregulation and Cancer Progression. Anti-Cancer Agents in Medicinal Chemistry 2019; 19(2): 236 doi: 10.2174/1871520618666181015142810
|
| 2 |
Aleksandar Cirovic, Soisungwan Satarug. Toxicity Tolerance in the Carcinogenesis of Environmental Cadmium. International Journal of Molecular Sciences 2024; 25(3): 1851 doi: 10.3390/ijms25031851
|
| 3 |
Kaige Deng, Jiali Xing, Gang Xu, Bao Jin, Xueshuai Wan, Yongchang Zheng, Shunda Du, Xinting Sang. Urinary biomarkers for hepatocellular carcinoma: current knowledge for clinicians. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-03092-5
|
| 4 |
Samy Kashkoush, Sherif Saleh, Walid Elmoghazy. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2016; : 1 doi: 10.1007/978-94-007-7742-2_34-1
|
| 5 |
Moamena S. El-Hamouly, Ayman A. Azzam, Samar E. Ghanem, Fathia I. EL-Bassal, Nashwa Shebl, Amira M. F. Shehata. Circulating microRNA-301 as a promising diagnostic biomarker of hepatitis C virus-related hepatocellular carcinoma. Molecular Biology Reports 2019; 46(6): 5759 doi: 10.1007/s11033-019-05009-w
|
| 6 |
Chi‐Ting Horng, Chien‐Wei Huang, Mon‐Yuan Yang, Tzu‐Hsin Chen, Yun‐Ching Chang, Chau‐Jong Wang. Nelumbo nucifera leaf extract treatment attenuated preneoplastic lesions and oxidative stress in the livers of diethylnitrosamine‐treated rats. Environmental Toxicology 2017; 32(11): 2327 doi: 10.1002/tox.22434
|
| 7 |
Sergio Ciordia, Gloria Alvarez-Sola, María Rullán, Jesús M. Urman, Matías A. Ávila, Fernando J. Corrales. Clinical Proteomics. Methods in Molecular Biology 2022; 2420: 1 doi: 10.1007/978-1-0716-1936-0_1
|
| 8 |
Romelia Pop, Dragoș Hodor, Cornel Cătoi, Teodora Mocan, Lucian Mocan, Alexandru-Flaviu Tăbăran. Unveiling the Role of Concanavalin A in a Rodent Model of Chemical-Induced Hepatocellular Carcinoma: A Promising Guide in Understanding Liver Cancer Development. Targets 2024; 2(1): 52 doi: 10.3390/targets2010003
|
| 9 |
Yuxin Chen, Yanping Wu, Xiao Zhang, Hong Zeng, Ya Liu, Qi Wu, Yan Chen, GuoQing Zhu, Qiuhui Pan, Lei Jin, Lin Guo, Fenyong Sun. Angiopoietin-2 (Ang-2) is a useful serum tumor marker for liver cancer in the Chinese population. Clinica Chimica Acta 2018; 478: 18 doi: 10.1016/j.cca.2017.12.017
|
| 10 |
Rui Caetano Oliveira, Ricardo Martins, Ana Margarida Abrantes, Ângela Jesus, Paulo Teixeira, Carolina Canhoto, Pedro Guerreiro, Beatriz Costa, Mário Rui Silva, José Guilherme Tralhão, Maria Augusta Cipriano. Morphophenotypic Classification of Hepatocellular Carcinoma: the Biliary/Stem Cell Subgroup and Worst Outcome—Implications on Patient Selection. Journal of Gastrointestinal Surgery 2021; 25(3): 698 doi: 10.1007/s11605-020-04611-9
|
| 11 |
Annabelle Pan, Thai N. Truong, Ying-Hsiu Su, Doan Y Dao. Circulating Biomarkers for the Early Diagnosis and Management of Hepatocellular Carcinoma with Potential Application in Resource-Limited Settings. Diagnostics 2023; 13(4): 676 doi: 10.3390/diagnostics13040676
|
| 12 |
Feng Zhou, Han-Zhang Huang, Meng-Tao Zhou, Shao-Liang Han. Surgical Treatment and Chemotherapy of Adult Primary Liver Sarcoma: Experiences from a Single Hospital in China. Digestive Surgery 2019; 36(1): 46 doi: 10.1159/000486454
|
| 13 |
Qian-Hui Xu, Pei-Wen Zhu, Biao Li, Wen-Qing Shi, Qi Lin, You-Lan Min, Qian-Min Ge, Qing Yuan, Yi Shao. Carbohydrate antigen-125, calcium, and hemoglobin as predictive clinical indicator for ocular metastasis in male liver cancer patients. Bioscience Reports 2020; 40(2) doi: 10.1042/BSR20194405
|
| 14 |
Takako Inoue, Yasuhito Tanaka. Novel biomarkers for the management of chronic hepatitis B. Clinical and Molecular Hepatology 2020; 26(3): 261 doi: 10.3350/cmh.2020.0032
|
| 15 |
Mona A. Omar, Mohamed M. Omran, Khaled Farid, Ashraf A. Tabll, Yasser E. Shahein, Tarek M. Emran, Ana Petrovic, Nikola R. Lucic, Robert Smolic, Tanja Kovac, Martina Smolic. Biomarkers for Hepatocellular Carcinoma: From Origin to Clinical Diagnosis. Biomedicines 2023; 11(7): 1852 doi: 10.3390/biomedicines11071852
|
| 16 |
Jin U. Kim, I. Jane Cox, Simon D. Taylor-Robinson. The Quest for Relevant Hepatocellular Carcinoma Biomarkers. Cellular and Molecular Gastroenterology and Hepatology 2017; 4(2): 283 doi: 10.1016/j.jcmgh.2017.06.003
|
| 17 |
Mustafa A. Barbhuiya, Adam C. Mirando, Brian W. Simons, Ghali Lemtiri-Chlieh, Jordan J. Green, Aleksander S. Popel, Niranjan B. Pandey, Phuoc T. Tran. Therapeutic potential of an anti-angiogenic multimodal biomimetic peptide in hepatocellular carcinoma. Oncotarget 2017; 8(60): 101520 doi: 10.18632/oncotarget.21148
|
| 18 |
Yunyang Chen, Shaoming Li, Wei Li, Rongbing Yang, Xianguang Zhang, Yong Ye, Jiexiong Yu, Lin Ye, Wangrong Tang. Circulating tumor cells undergoing EMT are poorly correlated with clinical stages or predictive of recurrence in hepatocellular carcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-43572-1
|
| 19 |
James Yu, Robin Park, Richard Kim. Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights. Journal of Hepatocellular Carcinoma 2023; : 1105 doi: 10.2147/JHC.S341195
|
| 20 |
Muhammad Afzal, Muhammad Imran, Samen Fatima, Muhammad Iqbal, Farkhanda Gillani, Nayyar Rubab, Owais Gill, Muhammad Naeem. 99mTc-MDP renal parenchymal retention on bone scan in hepatocellular carcinoma patients. Pakistan Journal of Nuclear Medicine 2020; : 31 doi: 10.24911/PJNMed.175-1574674085
|
| 21 |
Carina Hage, Sabine Hoves, Mailin Ashoff, Veronika Schandl, Stefan Hört, Natascha Rieder, Christian Heichinger, Marco Berrera, Carola H. Ries, Fabian Kiessling, Thomas Pöschinger, Roger Chammas. Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapy. PLOS ONE 2019; 14(7): e0219517 doi: 10.1371/journal.pone.0219517
|
| 22 |
Marwa A. Ali, Olfat G. Shaker, Eman M. Ezzat, Hanaa M. Eid, Doaa Y. Ali, Essam A. Hassan, Dalia H. Elsayed, Eman R. Abozaid, Omayma O. Abdelaleem. Serum lncRNAs, NBAT‐1, and FOXCUT signature in hepatocellular carcinoma developed on top of chronic hepatitis C. Molecular Carcinogenesis 2023; 62(3): 319 doi: 10.1002/mc.23488
|
| 23 |
Adi Zheng, Nadja Chevalier, Margot Calderoni, Gilles Dubuis, Olivier Dormond, Panos G. Ziros, Gerasimos P. Sykiotis, Christian Widmann. CRISPR/Cas9 genome-wide screening identifies KEAP1 as a sorafenib, lenvatinib, and regorafenib sensitivity gene in hepatocellular carcinoma. Oncotarget 2019; 10(66): 7058 doi: 10.18632/oncotarget.27361
|
| 24 |
Mahmood Barani, Muhammad Bilal, Abbas Rahdar, Rabia Arshad, Arun Kumar, Hamed Hamishekar, George Z. Kyzas. Nanodiagnosis and nanotreatment of colorectal cancer: an overview. Journal of Nanoparticle Research 2021; 23(1) doi: 10.1007/s11051-020-05129-6
|
| 25 |
Pro Kit Cheung, Man Hin Ma, Hing Fung Tse, Ka Fai Yeung, Hin Fung Tsang, Man Kee Maggie Chu, Chau Ming Kan, William Chi Shing Cho, Lawrence Bo Wah Ng, Lawrence Wing Chi Chan, Sze Chuen Cesar Wong. The applications of metabolomics in the molecular diagnostics of cancer. Expert Review of Molecular Diagnostics 2019; 19(9): 785 doi: 10.1080/14737159.2019.1656530
|
| 26 |
Houyong Long, Xingjun Guo, Shen Qiao, Qingxing Huang. Tumor LXR Expression is a Prognostic Marker for Patients with Hepatocellular Carcinoma. Pathology & Oncology Research 2018; 24(2): 339 doi: 10.1007/s12253-017-0249-8
|
| 27 |
Muhammad Shahzad Afzal, Muhammad Babar Imran, Muhammad Saeed Akhtar, Muhammad Iqbal. Increased renal parenchymal retention of 99mTc-MDP (hot kidneys) in two patients of Hepatocellular Cancer: one with and other without osseous metastases. European Journal of Medical Case Reports 2017; 1(2) doi: 10.24911/ejmcr/1/19
|
| 28 |
Chaoyuan Huang, Xiaotao Jiang, Yuancheng Huang, Lina Zhao, Peiwu Li, Fengbin Liu. Identifying Dendritic Cell–Related Genes Through a Co-Expression Network to Construct a 12-Gene Risk-Scoring Model for Predicting Hepatocellular Carcinoma Prognosis. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.636991
|
| 29 |
Yi Shi, Jingrui Men, Hongliang Sun, Jianjun Tan. The Identification and Analysis of MicroRNAs Combined Biomarkers for
Hepatocellular Carcinoma Diagnosis. Medicinal Chemistry 2022; 18(10): 1073 doi: 10.2174/1573406418666220404084532
|
| 30 |
Fei Huang, Junying Chen, Ruilong Lan, Zeng Wang, Ruiqing Chen, Jingan Lin, Lengxi Fu. Hypoxia induced δ-Catenin to enhance mice hepatocellular carcinoma progression via Wnt signaling. Experimental Cell Research 2019; 374(1): 94 doi: 10.1016/j.yexcr.2018.11.011
|
| 31 |
Xinxin Zhang, Jia Yu, Juan Hu, Fang Tan, Juan Zhou, Xiaoyan Yang, Zhizhong Xie, Huifang Tang, Sen Dong, Xiaoyong Lei. 13-lncRNAs Signature to Improve Diagnostic and Prognostic Prediction of Hepatocellular Carcinoma. Combinatorial Chemistry & High Throughput Screening 2021; 24(5): 656 doi: 10.2174/1386207323666200914095616
|
| 32 |
Amr Elrabat, Shahera Eletreby, Ahmed M. Ali Zaid, Mohammed H. Eldeen Zaghloul. Tumor necrosis factor-alpha and alpha-fetoprotein as biomarkers for diagnosis and follow-up of hepatocellular carcinoma before and after interventional therapy. The Egyptian Journal of Internal Medicine 2019; 31(4): 840 doi: 10.4103/ejim.ejim_73_19
|
| 33 |
James C. R. Wadkin, Daniel A. Patten, Sivesh K. Kamarajah, Emma L. Shepherd, Vera Novitskaya, Fedor Berditchevski, David H. Adams, Chris J. Weston, Shishir Shetty. CD151 supports VCAM-1-mediated lymphocyte adhesion to liver endothelium and is upregulated in chronic liver disease and hepatocellular carcinoma. American Journal of Physiology-Gastrointestinal and Liver Physiology 2017; 313(2): G138 doi: 10.1152/ajpgi.00411.2016
|
| 34 |
Susanne Smolka, Julius Chapiro, Wilfred Manzano, John Treilhard, Eric Reiner, Yanhong Deng, Yan Zhao, Bernd Hamm, James S. Duncan, Bernhard Gebauer, MingDe Lin, Jean-François Geschwind. The impact of antiangiogenic therapy combined with Transarterial Chemoembolization on enhancement based quantitative tumor response assessment in patients with hepatocellular carcinoma. Clinical Imaging 2017; 46: 1 doi: 10.1016/j.clinimag.2017.05.007
|
| 35 |
Liwen Zhang, Pengcheng Bu. The two sides of creatine in cancer. Trends in Cell Biology 2022; 32(5): 380 doi: 10.1016/j.tcb.2021.11.004
|
| 36 |
Junqi You, Haoming Xia, Ziyue Huang, Risheng He, Xudong Zhao, Jiali Chen, Sidi Liu, Yi Xu, Yunfu Cui. Research progress of circulating non-coding RNA in diagnosis and treatment of hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1204715
|
| 37 |
S Shalini, A Nikolic, C H Wilson, J Puccini, N Sladojevic, J Finnie, L Dorstyn, S Kumar. Caspase-2 deficiency accelerates chemically induced liver cancer in mice. Cell Death & Differentiation 2016; 23(10): 1727 doi: 10.1038/cdd.2016.81
|
| 38 |
Min Cong, Xiaojuan Ou, Jian Huang, Jiang Long, Tong Li, Xueen Liu, Yanhong Wang, Xiaoning Wu, Jialing Zhou, Yameng Sun, Qinghua Shang, Guofeng Chen, Hui Ma, Wen Xie, Hongxin Piao, Yongping Yang, Zhiliang Gao, Xiaoyuan Xu, Zongnan Tan, Chitty Chen, Na Zeng, Shanshan Wu, Yuanyuan Kong, Tianhui Liu, Ping Wang, Hong You, Jidong Jia, Hui Zhuang. A Predictive Model Using N-Glycan Biosignatures for Clinical Diagnosis of Early Hepatocellular Carcinoma Related to Hepatitis B Virus. OMICS: A Journal of Integrative Biology 2020; 24(7): 415 doi: 10.1089/omi.2020.0055
|
| 39 |
Bothina Madkour, Alaa Gad, Mona S. Hamdy, Nariman Zahran, Mohamed Aboul-Ezz. Interleukin-6-572 promoter gene polymorphism and its association with chronic hepatitis C-induced hepatocellular carcinoma: an Egyptian study. Comparative Clinical Pathology 2018; 27(1): 161 doi: 10.1007/s00580-017-2571-7
|
| 40 |
Liangliang Shi, Li Ba, Ying Xiong, Gang Peng. A hybridization chain reaction based assay for fluorometric determination of exosomes using magnetic nanoparticles and both aptamers and antibody as recognition elements. Microchimica Acta 2019; 186(12) doi: 10.1007/s00604-019-3823-9
|
| 41 |
Rafael Martín-Masot, María Jiménez-Muñoz, Marta Herrador-López, Víctor Manuel Navas-López, Elia Obis, Mariona Jové, Reinald Pamplona, Teresa Nestares. Metabolomic Profiling in Children with Celiac Disease: Beyond the Gluten-Free Diet. Nutrients 2023; 15(13): 2871 doi: 10.3390/nu15132871
|
| 42 |
Qingjia Chi, Xinge Geng, Kang Xu, Chunli Wang, Han Zhao. Potential targets and molecular mechanism of miR-331-3p in hepatocellular carcinoma identified by weighted gene coexpression network analysis. Bioscience Reports 2020; 40(6) doi: 10.1042/BSR20200124
|
| 43 |
Mohamed M. Omran, Khaled Farid, Mona A. Omar, Tarek M. Emran, Fathy M. El-Taweel, Ashraf A. Tabll. A combination of α-fetoprotein, midkine, thioredoxin and a metabolite for predicting hepatocellular carcinoma. Annals of Hepatology 2020; 19(2): 179 doi: 10.1016/j.aohep.2019.09.002
|
| 44 |
Samy Kashkoush, Sherif Saleh, Walid Elmoghazy. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; : 837 doi: 10.1007/978-94-007-7675-3_34
|
| 45 |
Inga Hochnadel, Uta Kossatz-Boehlert, Nils Jedicke, Henrike Lenzen, Michael P. Manns, Tetyana Yevsa. Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers. Human Vaccines & Immunotherapeutics 2017; 13(12): 2931 doi: 10.1080/21645515.2017.1359362
|
| 46 |
Shanshan Jiang, Qian Wang, Meiqing Feng, Jiyang Li, Zhongbin Guan, Duopeng An, Mengxue Dong, Yuzhe Peng, Kudelaidi Kuerban, Li Ye. C2-ceramide enhances sorafenib-induced caspase-dependent apoptosis via PI3K/AKT/mTOR and Erk signaling pathways in HCC cells. Applied Microbiology and Biotechnology 2017; 101(4): 1535 doi: 10.1007/s00253-016-7930-9
|
| 47 |
Lavinia Alice Balaceanu. Biomarkers <i>vs</i> imaging in the early detection of hepatocellular carcinoma and prognosis. World Journal of Clinical Cases 2019; 7(12): 1367-1382 doi: 10.12998/wjcc.v7.i12.1367
|
| 48 |
Hai-Mei Guo, Zhi-Feng Zhao, Yu-Qin Che, Jian-Hua Fan. Induction of Apoptosis in the Human HepG2 Hepatoma Cell Line Through the Extrinsic Pathway by Delphinium Alkaloid A. International Journal of Pharmacology 2021; 17(8): 562 doi: 10.3923/ijp.2021.562.571
|
| 49 |
Xin Xiong, Rong Rong, Li-Ying Tang, Tie Sun, Yi-Cong Pan, Hui-Ye Shu, Li-Juan Zhang, Qian-Min Ge, Rong-Bin Liang, Yi Shao. The Predictive Value of CA-125 and Hb for Ocular Metastasis in Hepatocellular Carcinoma Patients. Cancer Management and Research 2022; : 3405 doi: 10.2147/CMAR.S363115
|
| 50 |
Cristina Di Poto, Alessia Ferrarini, Yi Zhao, Rency S. Varghese, Chao Tu, Yiming Zuo, Minkun Wang, Mohammad R. Nezami Ranjbar, Yue Luo, Chi Zhang, Chirag S. Desai, Kirti Shetty, Mahlet G. Tadesse, Habtom W. Ressom. Metabolomic Characterization of Hepatocellular Carcinoma in Patients with Liver Cirrhosis for Biomarker Discovery. Cancer Epidemiology, Biomarkers & Prevention 2017; 26(5): 675 doi: 10.1158/1055-9965.EPI-16-0366
|
| 51 |
Keungmo Yang, Pil S. Sung, Young K. You, Dong G. Kim, Jung S. Oh, Ho J. Chun, Jeong W. Jang, Si H. Bae, Jong Y. Choi, Seung K. Yoon. Pathologic complete response to chemoembolization improves survival outcomes after curative surgery for hepatocellular carcinoma: predictive factors of response. HPB 2019; 21(12): 1718 doi: 10.1016/j.hpb.2019.04.017
|
| 52 |
Natalia I. Krupenko, Jaspreet Sharma, Halle M. Fogle, Peter Pediaditakis, Kyle C. Strickland, Xiuxia Du, Kristi L. Helke, Susan Sumner, Sergey A. Krupenko. Knockout of Putative Tumor Suppressor Aldh1l1 in Mice Reprograms Metabolism to Accelerate Growth of Tumors in a Diethylnitrosamine (DEN) Model of Liver Carcinogenesis. Cancers 2021; 13(13): 3219 doi: 10.3390/cancers13133219
|